CS Mitsiades. 2005. “CD44v6, a Target for Novel Antibody Treatment Approaches, Is Frequently Expressed in Multiple Myeloma and Associated With Deletion of Chromosome Arm 13q”. Haematologica 90 (4). Pavia, Italy, 436-37. https://haematologica.org/article/view/3504.